Effect of medroxyprogesterone acetate on sex hormone-binding globulin mRNA expression in the human endometrial cancer cell line Ishikawa

Ryou Misao, R Misao, Yoshihito Nakanishi, Y Nakanishi, J Fujimoto, Jiro Fujimoto, T Tamaya
European journal of endocrinology · 1998 · vol. 138(5) , pp. 574–582 · doi:10.1530/eje.0.1380574 · PMID:9625372 · W2098527137
Lab / animal OA: closed CC0 ⤵ 2 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Medroxyprogesterone acetate at high concentrations suppressed sex hormone-binding globulin mRNA expression in Ishikawa endometrial cancer cells, more effectively than other tested hormones.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

To understand the rationale of high-dose medroxyprogesterone acetate (MPA) in the treatment of well-differentiated uterine endometrial cancers, the effect of MPA on intracellular sex hormone-binding globulin (SHBG) mRNA expression in well-differentiated uterine endometrial cancer cell line Ishikawa was determined by competitive reverse transcription-polymerase chain reaction-Southern blot analysis. Estradiol-17beta (E2, 10(-8) mol/l) did not alter SHBG mRNA expression, but the addition of 10(-10) mol/l MPA increased it, while a high concentration of MPA (10(-6) to 10(-5) mol/l) with or without E2 suppressed it. Furthermore. a high dose (10(-6) mol/l) of chlormadinone acetate or danazol with or without E2 significantly suppressed its expression, while MPA was the most effective among the hormones tested. The effect of MPA and the other steroid hormone analogs on SHBG expression was not mediated via the progesterone receptor. These findings suggest that intracellular SHBG suppression might partly contribute to the abolition of the intracellular estrogen-dominant milieu, and may be involved as one of the mechanisms of the antitumoral effects of high-dose MPA on the development and growth of some well-differentiated endometrial cancer cells.

My notes (saved in your browser only)

MeSH descriptors

Antineoplastic Agents, Hormonal Endometrial Neoplasms Medroxyprogesterone Acetate RNA, Messenger Sex Hormone-Binding Globulin Antineoplastic Agents, Hormonal Cell Differentiation Cell Differentiation Endometrial Neoplasms Endometrial Neoplasms Female Humans Medroxyprogesterone Acetate Polymerase Chain Reaction Polymerase Chain Reaction RNA, Messenger Sex Hormone-Binding Globulin Transcription, Genetic Tumor Cells, Cultured

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (3)

Cited by (1)

References (37)

Cited by (1)

Source provenance

openalex
last seen: 2026-05-11T05:40:41.230350+00:00
pubmed
last seen: 2026-10-08T22:00:41.816812+00:00
unpaywall
last seen: 2026-10-22T06:24:31.118836+00:00
License: CC0 · commercial use OK